Afeditab CR and Gonadotropin, Chorionic

• Generic Name: nifedipine
• Dosage Forms: tablet, film coated, extended release
• Other Brand Names: Adalat CC, Afeditab CR, Nifediac CC, Nifedical XL, Procardia, Procardia XL, Adalat

Nifedipine is used alone or together with other medicines to treat severe chest pain (angina) or high blood pressure (hypertension). High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly. This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. High blood pressure may also increase the risk of heart attacks. These problems may be less likely to occur if blood pressure is controlled.

Nifedipine is a calcium channel blocker. It works by affecting the movement of calcium into the cells of the heart and blood vessels. As a result, nifedipine relaxes blood vessels and increases the supply of blood and oxygen to the heart while reducing its workload.

This medicine is available only with your doctor's prescription.

• Generic Name: chorionic gonadotropin (hcg)
• Dosage Forms: n.a.
• Other Brand Names: Novarel, Ovidrel, Pregnyl, APL, Profasi, Chorex, Gonic, Hcg, Chorigon, Choron-10

Management of prepubertal cryptorchidism not caused by anatomical obstruction.

Induction of testicular descent usually only temporary; response may be permanent in some patients.

Differential diagnosis (hCG stimulatory test) of cryptorchidism in prepubertal boys to predict whether subsequent orchidopexy will be required. In general, hCG is thought to induce testicular descent in patients in whom descent would have occurred at puberty.

Start corrective therapy for cryptorchidism before pubescence to prevent irreparable testicular damage; opinions differ regarding optimum age for treatment. Manufacturers recommend instituting u-hCG therapy for prepubertal cryptorchidism in boys 4–9 years of age.

Management of hypogonadotropic hypogonadism resulting from pituitary deficiency.

Stimulation of spermatogenesis in males with hypogonadotropic hypogonadism secondary to pituitary deficiency. Full response may require concurrent FSH or menotropins therapy.

Used in conjunction with follicle-stimulating agent(s) (e.g., menotropins as fixed-combination preparations or separate components, FSH) to induce ovulation in anovulatory, infertile women in whom anovulation is secondary (e.g., pituitary insufficiency).

Should not be used in infertile women in whom anovulation is due to primary ovarian failure.

Has been used for the treatment of infertility resulting from deficiency of corpus luteum during luteal phase of menstrual cycle.

Manufacturer states that u-hCG has not been shown to be effective as adjunctive therapy for the treatment of obesity.